The global nuclear safety and security framework (GNSSF) provides a conceptual structure and guidelines for achieving and maintaining a high level of safety and security at nuclear facilities and in nuclear related activities around the world. Technical and scientific support organizations (TSOs) play an essential role in sustaining the GNSSF by providing assistance to regulatory bodies in esta…
Models are essential tools in evaluating radiological impacts within the safety assessment process and regulatory control of facilities as well as of activities in planned exposure situations, existing exposure situations and emergency exposure situations. Modelling the transfer of radionuclides in the environment and assessing the resulting radiation exposure of people and the environment is n…
This Safety Guide provides recommendations on how to comply with IAEA safety requirements on leadership and management for safety in the area of radioactive waste management. It presents updated guidance on developing and implementing management systems for safety during all steps of radioactive waste management. Emphasis is placed upon effective leadership and culture for safety. The publicati…
The IAEA’s Statute authorizes it to “establish…standards of safety for protection of health and minimization of danger to life and property”. These are standards that the IAEA must apply to its own operations, and that States can apply through their national regulations. Radioactivity is a natural phenomenon and natural sources of radiation are features of the environment. Radiation…
Radioactivity is a natural phenomenon and natural sources of radiation are features of the environment. Radiation and radioactive substances have many beneficial applications, ranging from power generation to uses in medicine, industry and agriculture. The radiation risks to workers and the public and to the environment that may arise from these applications have to be assessed and, if necessar…
Radiotherapy is one of the major treatment modalities for cancer, along with surgery and chemotherapy. It has been shown to be cost effective in many countries, including in low and middle income countries (LMICs) [1, 2]. Depending on the predominance of specific cancers in the geographic region in question, approximately 40–60% of all cancer patients can benefit from radiotherapy [3–6]. …
In recent years there has been a rapid development in models and approaches to assess whether the environment (or wildlife) is protected from releases of radioactive material. Through the Environmental Modelling for Radiation Safety (EMRAS and EMRAS II) and Modelling and Data for Radiological Impact Assessments (MODARIA I and MODARIA II) programmes, the IAEA has facilitated knowledge sharing on…
This report contains the 52nd edition of the IAEA’s series of annual reports on operating experience with nuclear power plants in Member States. It is a direct output from the IAEA’s Power Reactor Information System (PRIS) and contains information on electricity production and overall performance of individual plants during 2020. In addition to annual information, the report contains a hist…
Therapeutic radiopharmaceuticals play a major role in today's nuclear medicine with a positive impact on the diagnosis and treatment of diseases. One area of application is radiation synovectomy (RSV). Previously, RSV agents were often simple colloids. More recently, matrixes labelled with short/medium range beta emitters have been developed. However, the lack of generic and peer-reviewed produ…
This publication provides comprehensive detailed guidance for States, competent authorities and operators on how to implement the recommendations and implementing guidance of existing IAEA Nuclear Security Series publications for an effective physical protection system (PPS) for nuclear facilities and nuclear materials in use and storage. It provides further technical detail on how to design an…